how safe are glp 1 Comparative efficacy and safety of GLP-1 receptor agonists for weight reduction: A model-based meta-analysis of placebo-controlled trials So many questions about GLP-1.

In certain instances, once exposure to an active agent (e.g., concentration in the endolymph or perilymph) reaches steady state, the concentration of an active agent in the endolymph or perilymph stays at or about the therapeutic dose for an extended period of time (e.g., one day, 2 days, 3 days, 4 days, 5 days, 6 days, 1 week, 3 weeks, 6 weeks, or 2 months)

As more studies took place, healthcare professionals found another key result: many patients using semaglutide lost significant weight

Another physical indicator is decreased urine output

Nature 442 , 307311 (2006)

Evolutionary divergence and convergence in proteins

[DOI] [PMC free article] [PubMed] [Google Scholar] 68.Cha S.J., Kim H., Choi H.J., Lee S., Kim K